Premium
Cancer Therapy: Dendritic Platinum–Copper Alloy Nanoparticles as Theranostic Agents for Multimodal Imaging and Combined Chemophotothermal Therapy (Adv. Funct. Mater. 33/2016)
Author(s) -
Zhou Zhengjie,
Hu Kewen,
Ma Rui,
Yan Yang,
Ni Bing,
Zhang Yunjiao,
Wen Longping,
Zhang Qiang,
Cheng Yiyun
Publication year - 2016
Publication title -
advanced functional materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.069
H-Index - 322
eISSN - 1616-3028
pISSN - 1616-301X
DOI - 10.1002/adfm.201670212
Subject(s) - photothermal therapy , materials science , cancer therapy , nanotechnology , nanoparticle , platinum , copper , platinum nanoparticles , drug delivery , tumor ablation , biomedical engineering , cancer , ablation , metallurgy , medicine , organic chemistry , chemistry , catalysis
On page 5971, Q. Zhang, Y. Cheng, and co‐workers describe a dendritic platinum‐copper alloy nanoparticle (DPCN) inherently possessing multimodal image modalities, photothermal effect, drug loading capability, and responsive release behaviors. Efficient tumor ablation in DPCN‐mediated chemo‐photothermal therapy proves the potential of this approach for cancer therapy.